<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Chlorpromazine Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects</title>
  <meta name="description" content="Chlorpromazine Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects — Pharmacology Course" />
  <link rel="stylesheet" href="style.css">
</head>
<body>

  <!-- Header -->
  <header class="site-header">
    <div class="container">
      <div class="logo">
        <a href="index.html">Dr M Medical Courses</a>
      </div>
      <nav class="main-nav">
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="orthopedics.html">Orthopedics Courses</a></li>
          <li><a href="pharmacology.html">Pharmacology Courses</a></li>
          <li><a href="about.html">About</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <main>
    <header>
      <h1>Chlorpromazine Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects</h1>
      <p class="lead">Overview, pharmacokinetics, mechanism, uses, dosing, and adverse effects of chlorpromazine.</p>
    </header>

    <section id="overview">
      <h2>Overview</h2>
      <ul>
        <li>Famous trade names: Thorazine and Largactil</li>
        <li>Classified as low potency typical antipsychotic drug from phenothiazines family</li>
        <li>Used in treatment of schizophrenia and some other mental disorders</li>
        <li>Chlorpromazine was developed in 1950 and it was the first antipsychotic</li>
      </ul>
    </section>

    <section id="pharmacokinetics">
      <h2>Pharmacokinetics</h2>
      <ul>
        <li>Chlorpromazine is available as oral, IM, IV formulas</li>
        <li>Oral absorption is variable with bioavailability of 10-90%</li>
        <li>Widely distributed through the body, high lipid solubility so it easily crosses blood brain barrier to CNS</li>
        <li>Extensively metabolized in the liver by CYP enzymes especially CYPA12 and 2D6, also metabolized by kidney and GIT</li>
        <li>Excreted in urine</li>
      </ul>
    </section>

    <section id="mechanism">
      <h2>Mechanism of Action</h2>
      <ul>
        <li>Chlorpromazine works by antagonizing dopamine D2 receptors in the brain</li>
        <li>Blocks dopamine in the mesolimbic and mesocortical pathway → relieves psychotic symptoms</li>
        <li>Blocks dopamine in the nigrostriatal pathway → extrapyramidal symptoms as adverse effects</li>
        <li>Blocks dopamine in the tuberoinfundibular pathway → hyperprolactinemia as an adverse effect</li>
        <li>Also has anti-serotonin, antimuscarinic, and anti-histamine activity</li>
        <li>Blocks alpha adrenergic receptors to some degree too</li>
      </ul>
    </section>

    <section id="therapeutic-uses">
      <h2>Therapeutic Uses</h2>
      <ul>
        <li>Treatment of psychosis including schizophrenia</li>
        <li>Manic phase of Bipolar disorder</li>
        <li>Treatment of chronic hiccups</li>
        <li>Treatment of nausea and vomiting not responding to first line medications (anti-emetic effect from blocking dopamine, histamine, and muscarinic receptors in vomiting center)</li>
        <li>Treatment of agitation and severe anxiety</li>
        <li>Off label: migraine and serotonin syndrome</li>
      </ul>
    </section>

    <section id="dosing">
      <h2>Dosing</h2>
      <ul>
        <li><strong>For schizophrenia</strong></li>
        <ul>
          <li>Oral: start 25-75 mg/day orally twice per day, maintain at 200 mg/day, max 800 mg/day</li>
          <li>IM/IV: 25 mg then 50 mg after 1-4 hours, repeat, dose can be 300-800 mg/day</li>
        </ul>
        <li><strong>For nausea and vomiting</strong></li>
        <ul>
          <li>Oral: 10-25 mg every 4-6 hours as needed</li>
          <li>IM/IV: 25-50 mg every 4-6 hours as needed</li>
        </ul>
      </ul>
    </section>

    <section id="adverse-effects">
      <h2>Adverse Effects</h2>
      <ul>
        <li>Extrapyramidal symptoms (movement disorders): tremor, dyskinesia, akathisia (less than other typicals)</li>
        <li>Neuroleptic malignant syndrome</li>
        <li>More anticholinergic side effects (blurred vision, dry mouth, sedation, constipation)</li>
        <li>Blocks alpha adrenergic receptors → postural hypotension</li>
        <li>Mild bone marrow suppression</li>
        <li>Increased prolactin → decreased libido, gynecomastia, galactorrhea, erectile dysfunction</li>
      </ul>
    </section>

    <section id="contraindications">
      <h2>Contraindications</h2>
      <ul>
        <li>Previous hypersensitivity reaction to the drug</li>
        <li>CNS depression, coma</li>
        <li>Bone marrow suppression</li>
        <li>Hepatic failure and acute liver disease</li>
        <li>Pheochromocytoma</li>
      </ul>
    </section>

    <section id="cautions">
      <h2>Cautions</h2>
      <ul>
        <li>Risk of closed angle glaucoma in elderly patients taking this medication</li>
      </ul>
    </section>
  </main>

  <footer>
    <p>&copy; 2025 Dr M. All Rights Reserved.</p>
  </footer>

</body>
</html>